These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 4018098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunological and isoelectric focusing study of beta-glucocerebrosidase from normal and Gaucher disease.
    Hardy B, Hoffman J, Ossimi Z.
    Biochem Biophys Res Commun; 1984 Apr 30; 120(2):325-32. PubMed ID: 6375656
    [Abstract] [Full Text] [Related]

  • 4. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
    Gonzales ML, Basu A, de Haas GH, Dijkman R, van Oort MG, Okolo AA, Glew RH.
    Arch Biochem Biophys; 1988 Apr 30; 262(1):345-53. PubMed ID: 3355173
    [Abstract] [Full Text] [Related]

  • 5. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH, Daniels LB, Clark LS, Hoyer SW.
    J Neuropathol Exp Neurol; 1982 Nov 30; 41(6):630-41. PubMed ID: 6813430
    [Abstract] [Full Text] [Related]

  • 6. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
    Daniels LB, Coyle PJ, Chiao YB, Glew RH, Labow RS.
    J Biol Chem; 1981 Dec 25; 256(24):13004-13. PubMed ID: 6796580
    [Abstract] [Full Text] [Related]

  • 7. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A, Prence E, Garrett K, Glew RH, Ellingson JS.
    Arch Biochem Biophys; 1985 Nov 15; 243(1):28-34. PubMed ID: 3933429
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
    Choy FY, Davidson RG.
    Pediatr Res; 1980 Jan 15; 14(1):54-9. PubMed ID: 6767218
    [Abstract] [Full Text] [Related]

  • 12. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO, Prence EM, Glew RH.
    Arch Biochem Biophys; 1985 Apr 15; 238(1):344-52. PubMed ID: 3920967
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
    Yaqoob M, Carroll M.
    Clin Genet; 1981 Aug 15; 20(2):161-7. PubMed ID: 6796311
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.
    Prence EM, Garrett KO, Panitch H, Basu A, Glew RH, Wherrett JR, Huterer S.
    Clin Chim Acta; 1986 Apr 30; 156(2):179-89. PubMed ID: 3085988
    [Abstract] [Full Text] [Related]

  • 17. Properties of acid ceramidase from human spleen.
    Al BJ, Tiffany CW, Gomes de Mesquita DS, Moser HW, Tager JM, Schram AW.
    Biochim Biophys Acta; 1989 Aug 08; 1004(2):245-51. PubMed ID: 2526656
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.